Metromile
-
Part One of a deep dive by our research team into Metromile’s business model. -
The stratospheric rise of Lemonade’s share price in its opening days raises the question of whether other InsurTechs will now rush to list on the public markets.
Related
-
Lemonade & Root Q2: Low-Fidelity
August 11, 2022 -
Lemonade agrees to sell Metromile’s EBS business to EIS
August 01, 2022 -
Comp rankings: InsurTech execs jostle for top spots
July 14, 2022